Advertisement

Topics

Synthon Chiragenics Corporation Company Profile

08:52 EDT 24th June 2018 | BioPortfolio

Synthon Chiragenics Corporation is a world-leader in carbohydrate-based chiral technology for pharmaceuticals. Unlike proteins and amino acids that have been the target of biomedical research for decades, carbohydrate chemistry has eluded researchers because of the complexity of the molecules and the difficulty of working with them. Synthon is the first and only company to unlock the rich source of chirality contained in naturally occurring carbohydrates. The company uses its proprietary technology to economically construct the most challenging chiral molecules, which serve as cores for drugs being developed in the fastest-growing therapeutic areas: anti-virals, antibiotics and anti-cancer.These "drugs of the future" are the most difficult and expensive to make because they possess multiple chiral centers. The company's strategy is to start with naturally occurring, readily available carbohydrates that have the chirality already built-in. Carbohydrates are unique because they have multiple contiguous chiral centers, which can be manipulated to form desired drug intermediates more cost-effectively than other methods.

Location

7 Deer Park Drive
Monmouth Junction
New Jersey
08852
United States of America

Contact

Phone: 732-274-0037
Fax: 732-274-0502
Email: info@synthoncorp.com


News Articles [93 Associated News Articles listed on BioPortfolio]

Synthon’s SYD985 fast tracked for metastatic breast cancer

Netherlands-based Synthon Biopharmaceuticals has obtained fast-track designation from the US Food and Drug Administration (FDA) for its investigational antibody-drug conjugate...Read More... The post ...

Synthon’s SYD985 granted FDA fast track status for pre-treated HER2-positive metastatic breast cancer

Synthon Biopharmaceuticals has secured has granted Fast track designation from the US Food & Drug Administration (FDA) for its investigational anti-HER2 antibody-drug conjugate (ADC) [vic-]trastuzumab...

Orion Corporation: Managers' transactions - Ari Lehtoranta

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EETS Orion Corporation: Managers' transactions - Ari Lehtoranta Orion Corporation has received the...

Orion Corporation: Managers' transactions - Liisa Hurme

ORION CORPORATION         MANAGERS' TRANSACTIONS 2nd of March 2018 at 9.45 EET Orion Corporation: Managers' transactions - Liisa Hurme Orion Corporation has received...

Orion Corporation: Managers' transactions - Timo Maasilta

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EETS Orion Corporation: Managers' transactions - Timo Maasilta Orion Corporation has received the ...

Orion Corporation: Managers' transactions - Mikael Silvennoinen

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EEST              Orion Corporation: Managers' transactions - Mikael Silvennoinen Orio...

Orion Corporation: Managers' transactions - Sirpa Jalkanen

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EETS Orion Corporation: Managers' transactions - Sirpa Jalkanen Orion Corporation has received the ...

Orion Corporation: Managers' transactions - Eija Ronkainen

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EEST Orion Corporation: Managers' transactions - Eija Ronkainen Orion Corporation has received...

PubMed Articles [8 Associated PubMed Articles listed on BioPortfolio]

Design of Trifluoroalkenyliodonium salts for Hypervalency Aided Alkenylation-Cyclization Strategy: Metal-free Construction of Aziridine Ring.

Synthesis of fluorinated compounds and their use as pharmaceutical ingredients or synthetic building blocks are in the focus of chemical and medicinal research. However, the efficient synthesis of tri...

New Water-Soluble Cluster Compound {Zn(en)}VSbO(HO)⋅ (Ethylenediamine)⋅10 HO as a Synthon for the Generation of Two New Antimonato Polyoxovanadates.

A new antimonato polyoxovanadate {Zn(en)}[VSbO(HO)]⋅3 en⋅10 HO (en=ethylenediamine) synthesized under hydrothermal conditions exhibits remarkable solubility in water. Electrospray ionization m...

Simple Organic Salts Having Naphthalenediimide (NDI) Core Displaying Multi-functional Properties: Gelation, Anti-cancer and Semiconducting Properties.

Following a supramolecular synthon rationale a dicarboxylic acid derivative having naphthalenediimide (NDI) core namely bis-N-carboxymethyl naphthalenediimide (NDI-A) was reacted with n-alkyl amines h...

Sustainable Phosphorus Chemistry: A Silylphosphide Synthon for the Generation of Value-Added Phosphorus Chemicals.

Avoiding white phosphorus: Cummins and Geeson have recently described the conversion of phosphoric acid into the novel bis(trichlorosilyl)phosphide anion, which serves as a key intermediate in the syn...

Transformation of Sugars to Chiral Polyols over a Heterogeneous Catalyst.

Transformation of sugars with maintaining the intrinsic stereostructure is desirable to make full use of sugars, however, there is no choice but to use multistep synthesis with protection and deprotec...

Clinical Trials [0 Results]

None

Companies [177 Associated Companies listed on BioPortfolio]

Synthon Chiragenics Corporation

Synthon Chiragenics Corporation is a world-leader in carbohydrate-based chiral technology for pharmaceuticals. Unlike proteins and amino acids that have been the target of biomedical research for deca...

Synthon Biopharmaceuticals

Synthon, with headquarters in Nijmegen, the Netherlands, is an international pharmaceutical company and a leader in the field of generic medicines. The company started its biophar...

Synthon Pharmaceuticals, Inc.

Synthon is an independent group of affiliated pharmaceutical companies dedicated to the development, registration, production, marketing and distribution of a wide range of pharmaceutical products. Fo...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Bruker Daltonics

Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...

More Information about "Synthon Chiragenics Corporation" on BioPortfolio

We have published hundreds of Synthon Chiragenics Corporation news stories on BioPortfolio along with dozens of Synthon Chiragenics Corporation Clinical Trials and PubMed Articles about Synthon Chiragenics Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Synthon Chiragenics Corporation Companies in our database. You can also find out about relevant Synthon Chiragenics Corporation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record